Back
Affimed NV 10K Form
Sell
23
AFMD
Affimed NV
Last Price:
2.64
Seasonality Move:
4.14%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive AFMD News And Ratings
See the #1 stock for the next 7 days that we like better than AFMD
AFMD Financial Statistics
Sales & Book Value
| Annual Sales: | $8.96M |
|---|---|
| Cash Flow: | $-13.18M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.17 |
| Price / Book: | 2.7 |
Profitability
| EPS (TTM): | -4.95460 |
|---|---|
| Net Income (TTM): | $-75.87M |
| Gross Margin: | $0 |
| Return on Equity: | -158.94% |
| Return on Assets: | -91.92% |
Affimed NV Earnings Forecast
Key Affimed NV Financial Ratios
- The Gross Profit Margin over the past 4 years for AFMD is 0.00%.
- The Selling, General & Administrative Expenses for AFMD have been equal to 298.19% of Gross Profit Margin.
- The Research & Development expenses have been 1,147.53% of Revenue.
- The Interest Expense is -1.70% of Operating Income.
- The Net Earning history of AFMD is -1,280.22% of Total Revenues.
- Per Share Earnings over the last 12 years have been positive in 4 years.
Affimed NV Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | AFMD |
| Website: | affimed.com |
Debt
| Debt-to-Equity Ratio: | 0.47 |
|---|---|
| Current Ratio: | 1.93 |
| Quick Ratio: | 1.76 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
AFMD Technical Analysis vs Fundamental Analysis
Sell
23
Affimed NV (AFMD)
is a Sell
Is Affimed NV a Buy or a Sell?
-
Affimed NV stock is rated a Sell
The current Affimed NV [AFMD] share price is $2.72. The Score for AFMD is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.